Copyright Reports & Markets. All rights reserved.

Global Immunosuppressant for Systemic Lupus Erythematosus Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Cyclophosphamide
      • 1.4.3 Mycophenolate Mofetil
      • 1.4.4 Azathioprine
      • 1.4.5 Cyclosporine A
      • 1.4.6 Tacrolimus
      • 1.4.7 Methotrexate
      • 1.4.8 Leflunomide
      • 1.4.9 Vincristine
      • 1.4.10 Other
    • 1.5 Market by Application
      • 1.5.1 Global Immunosuppressant for Systemic Lupus Erythematosus Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Pharmacy
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Immunosuppressant for Systemic Lupus Erythematosus Market Size
    • 2.2 Immunosuppressant for Systemic Lupus Erythematosus Growth Trends by Regions
      • 2.2.1 Immunosuppressant for Systemic Lupus Erythematosus Market Size by Regions (2014-2025)
      • 2.2.2 Immunosuppressant for Systemic Lupus Erythematosus Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Immunosuppressant for Systemic Lupus Erythematosus Market Size by by Players
      • 3.1.1 Global Immunosuppressant for Systemic Lupus Erythematosus Revenue by by Players (2014-2019)
      • 3.1.2 Global Immunosuppressant for Systemic Lupus Erythematosus Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Immunosuppressant for Systemic Lupus Erythematosus Market Concentration Ratio (CR5 and HHI)
    • 3.2 Immunosuppressant for Systemic Lupus Erythematosus Key Players Head office and Area Served
    • 3.3 Key Players Immunosuppressant for Systemic Lupus Erythematosus Product/Solution/Service
    • 3.4 Date of Enter into Immunosuppressant for Systemic Lupus Erythematosus Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type (2014-2019)
    • 4.2 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Immunosuppressant for Systemic Lupus Erythematosus Market Size (2014-2019)
    • 5.2 Immunosuppressant for Systemic Lupus Erythematosus Key Players in United States
    • 5.3 United States Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
    • 5.4 United States Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application

    6 Europe

    • 6.1 Europe Immunosuppressant for Systemic Lupus Erythematosus Market Size (2014-2019)
    • 6.2 Immunosuppressant for Systemic Lupus Erythematosus Key Players in Europe
    • 6.3 Europe Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
    • 6.4 Europe Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application

    7 China

    • 7.1 China Immunosuppressant for Systemic Lupus Erythematosus Market Size (2014-2019)
    • 7.2 Immunosuppressant for Systemic Lupus Erythematosus Key Players in China
    • 7.3 China Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
    • 7.4 China Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application

    8 Japan

    • 8.1 Japan Immunosuppressant for Systemic Lupus Erythematosus Market Size (2014-2019)
    • 8.2 Immunosuppressant for Systemic Lupus Erythematosus Key Players in Japan
    • 8.3 Japan Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
    • 8.4 Japan Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Immunosuppressant for Systemic Lupus Erythematosus Market Size (2014-2019)
    • 9.2 Immunosuppressant for Systemic Lupus Erythematosus Key Players in Southeast Asia
    • 9.3 Southeast Asia Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
    • 9.4 Southeast Asia Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application

    10 India

    • 10.1 India Immunosuppressant for Systemic Lupus Erythematosus Market Size (2014-2019)
    • 10.2 Immunosuppressant for Systemic Lupus Erythematosus Key Players in India
    • 10.3 India Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
    • 10.4 India Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Immunosuppressant for Systemic Lupus Erythematosus Market Size (2014-2019)
    • 11.2 Immunosuppressant for Systemic Lupus Erythematosus Key Players in Central & South America
    • 11.3 Central & South America Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
    • 11.4 Central & South America Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application

    12 International Players Profiles

    • 12.1 Alcon
      • 12.1.1 Alcon Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Immunosuppressant for Systemic Lupus Erythematosus Introduction
      • 12.1.4 Alcon Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2014-2019)
      • 12.1.5 Alcon Recent Development
    • 12.2 Alkem Laboratories
      • 12.2.1 Alkem Laboratories Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Immunosuppressant for Systemic Lupus Erythematosus Introduction
      • 12.2.4 Alkem Laboratories Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2014-2019)
      • 12.2.5 Alkem Laboratories Recent Development
    • 12.3 Allergan
      • 12.3.1 Allergan Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Immunosuppressant for Systemic Lupus Erythematosus Introduction
      • 12.3.4 Allergan Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2014-2019)
      • 12.3.5 Allergan Recent Development
    • 12.4 Amneal Pharmaceuticals
      • 12.4.1 Amneal Pharmaceuticals Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Immunosuppressant for Systemic Lupus Erythematosus Introduction
      • 12.4.4 Amneal Pharmaceuticals Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2014-2019)
      • 12.4.5 Amneal Pharmaceuticals Recent Development
    • 12.5 Astellas Pharma
      • 12.5.1 Astellas Pharma Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Immunosuppressant for Systemic Lupus Erythematosus Introduction
      • 12.5.4 Astellas Pharma Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2014-2019)
      • 12.5.5 Astellas Pharma Recent Development
    • 12.6 Baxter
      • 12.6.1 Baxter Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Immunosuppressant for Systemic Lupus Erythematosus Introduction
      • 12.6.4 Baxter Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2014-2019)
      • 12.6.5 Baxter Recent Development
    • 12.7 Beijing Jialin Pharmaceutical
      • 12.7.1 Beijing Jialin Pharmaceutical Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Immunosuppressant for Systemic Lupus Erythematosus Introduction
      • 12.7.4 Beijing Jialin Pharmaceutical Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2014-2019)
      • 12.7.5 Beijing Jialin Pharmaceutical Recent Development
    • 12.8 Genentech
      • 12.8.1 Genentech Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Immunosuppressant for Systemic Lupus Erythematosus Introduction
      • 12.8.4 Genentech Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2014-2019)
      • 12.8.5 Genentech Recent Development
    • 12.9 Jubilant Cadista
      • 12.9.1 Jubilant Cadista Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Immunosuppressant for Systemic Lupus Erythematosus Introduction
      • 12.9.4 Jubilant Cadista Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2014-2019)
      • 12.9.5 Jubilant Cadista Recent Development
    • 12.10 LGM Pharma
      • 12.10.1 LGM Pharma Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Immunosuppressant for Systemic Lupus Erythematosus Introduction
      • 12.10.4 LGM Pharma Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2014-2019)
      • 12.10.5 LGM Pharma Recent Development
    • 12.11 LingNan Pharmaceutical
    • 12.12 Merck
    • 12.13 Mimetogen Pharmaceuticals
    • 12.14 Mylan
    • 12.15 Otsuka Pharmaceutical
    • 12.16 Par Pharmaceutical
    • 12.17 Pfizer
    • 12.18 Powerdone
    • 12.19 Regenerx Biopharmaceuticals
    • 12.20 Roxane Laboratories
    • 12.21 Sandoz
    • 12.22 Sanofi
    • 12.23 Santen Pharmaceutical
    • 12.24 Shire
    • 12.25 Sine
    • 12.26 Strides Pharma
    • 12.27 Talon Therapeutics
    • 12.28 Teva
    • 12.29 United Biotech
    • 12.30 West Ward Pharmaceuticals

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Immunosuppressant for Systemic Lupus Erythematosus market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Immunosuppressant for Systemic Lupus Erythematosus status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunosuppressant for Systemic Lupus Erythematosus development in United States, Europe and China.

      The key players covered in this study
      Alcon
      Alkem Laboratories
      Allergan
      Amneal Pharmaceuticals
      Astellas Pharma
      Baxter
      Beijing Jialin Pharmaceutical
      Genentech
      Jubilant Cadista
      LGM Pharma
      LingNan Pharmaceutical
      Merck
      Mimetogen Pharmaceuticals
      Mylan
      Otsuka Pharmaceutical
      Par Pharmaceutical
      Pfizer
      Powerdone
      Regenerx Biopharmaceuticals
      Roxane Laboratories
      Sandoz
      Sanofi
      Santen Pharmaceutical
      Shire
      Sine
      Strides Pharma
      Talon Therapeutics
      Teva
      United Biotech
      West Ward Pharmaceuticals

      Market segment by Type, the product can be split into
      Cyclophosphamide
      Mycophenolate Mofetil
      Azathioprine
      Cyclosporine A
      Tacrolimus
      Methotrexate
      Leflunomide
      Vincristine
      Other

      Market segment by Application, split into
      Hospital
      Clinic
      Pharmacy
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Immunosuppressant for Systemic Lupus Erythematosus status, future forecast, growth opportunity, key market and key players.
      To present the Immunosuppressant for Systemic Lupus Erythematosus development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Immunosuppressant for Systemic Lupus Erythematosus are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now